West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
223.88
+1.68 (0.76%)
Mar 31, 2025, 4:00 PM EDT - Market closed

WST Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
484.6853.9894.3762.6615.5
Upgrade
Cash & Short-Term Investments
484.6853.9894.3762.6615.5
Upgrade
Cash Growth
-43.25%-4.52%17.27%23.90%40.17%
Upgrade
Receivables
575.8533.5523.7503.6385.3
Upgrade
Inventory
377434.7414.8378.4321.3
Upgrade
Other Current Assets
100.7114.386.797.451.6
Upgrade
Total Current Assets
1,5381,9361,9201,7421,374
Upgrade
Property, Plant & Equipment
1,7161,5131,2631,1271,012
Upgrade
Long-Term Investments
202.1210204.9207.7214.7
Upgrade
Goodwill
106108.5107.3109.9111.1
Upgrade
Other Intangible Assets
10.815.118.42330.5
Upgrade
Long-Term Accounts Receivable
----10.9
Upgrade
Long-Term Deferred Tax Assets
2625.765.648.516
Upgrade
Long-Term Deferred Charges
----0.4
Upgrade
Other Long-Term Assets
44.621.338.455.925
Upgrade
Total Assets
3,6433,8303,6173,3142,794
Upgrade
Accounts Payable
239.3242.4215.4232.2213.1
Upgrade
Accrued Expenses
138161.3141.1186.1149.1
Upgrade
Current Portion of Long-Term Debt
-1342.244.22.3
Upgrade
Current Portion of Leases
18.817.7169.310.1
Upgrade
Current Income Taxes Payable
31.516.629.526.326
Upgrade
Current Unearned Revenue
49.641.757.348.751
Upgrade
Other Current Liabilities
73.258.157.547.351.8
Upgrade
Total Current Liabilities
550.4671.8519594.1503.4
Upgrade
Long-Term Debt
202.672.8206.7208.8258.5
Upgrade
Long-Term Leases
83.984.5936360.4
Upgrade
Long-Term Unearned Revenue
3.612.210.9--
Upgrade
Long-Term Deferred Tax Liabilities
20.512.714.34.910.4
Upgrade
Other Long-Term Liabilities
71.964.959.867.149.1
Upgrade
Total Liabilities
961.1948.5931.9978.4939.3
Upgrade
Common Stock
18.818.818.818.818.8
Upgrade
Additional Paid-In Capital
22.1120.2232.2249267.3
Upgrade
Retained Earnings
3,9573,5232,9882,4571,847
Upgrade
Treasury Stock
-1,057-637.6-370.9-229.5-167.7
Upgrade
Comprehensive Income & Other
-258.1-143.8-183-159.6-110.6
Upgrade
Shareholders' Equity
2,6822,8812,6852,3351,855
Upgrade
Total Liabilities & Equity
3,6433,8303,6173,3142,794
Upgrade
Total Debt
305.3309317.9325.3331.3
Upgrade
Net Cash (Debt)
179.3544.9576.4437.3284.2
Upgrade
Net Cash Growth
-67.09%-5.46%31.81%53.87%162.18%
Upgrade
Net Cash Per Share
2.437.247.605.733.75
Upgrade
Filing Date Shares Outstanding
72.373.374.1474.2874.1
Upgrade
Total Common Shares Outstanding
72.373.574.174.274.02
Upgrade
Working Capital
987.71,2651,4011,148870.3
Upgrade
Book Value Per Share
37.1039.2036.2331.4725.05
Upgrade
Tangible Book Value
2,5662,7572,5592,2031,713
Upgrade
Tangible Book Value Per Share
35.4837.5234.5429.6823.14
Upgrade
Land
27.933.72929.324.8
Upgrade
Buildings
916.1771.5663.6644.8618.1
Upgrade
Machinery
1,6311,5181,3881,2981,201
Upgrade
Construction In Progress
410.8415.2305.9242.7192.1
Upgrade
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q